Topics on OncologyPRO

Categorised scientific content throughout OncologyPRO

What does this mean?

  • Topics pages: these allow you to go directly to your topic of interest and get a list of all content on OncologyPRO that has been tagged with this topic. This list is sorted by date so the most recent information appears at the top.
  • What's the latest in: this box, available on the OncologyPRO homepage, allows you to go directly to your topic page of interest.
  • Filtered lists: you can filter news and meeting resources lists by selecting the topic in the scroll-down bar above the list.
  • Refined searches: all search areas across the site allow you to refine results by topic by using the left-hand ‘Refine’ options.

Where does this list come from?

The topics chosen to categorise OncologyPRO were extracted from the Global Curriculum in Medical Oncology. For simplicity, a sub-set of topics which cover the whole curriculum were selected keeping a 2-level taxonomy for OncologyPRO.

What is the taxonomy used on OncologyPRO?

Anti-Cancer Agents & Biologic Therapy

Basic Science: includes research done in vitro and in animal models.

Bioethics, Legal,and Economic Issues: includes informed consent, research ethics, ethical and legal issues in end-of-life care, cost effectiveness of cancer drugs, conflict of interest and professional conduct.

  • Career Development: includes Young Oncologist sessions at events, how-to tips, and fellowship information.

Breast Cancer

Cancer Aetiology, Epidemiology, Prevention: includes primary and secondary screening.

Cancer Immunology and Immunotherapy

Cancer in Special Situations

Carcinoma of Unknown Primary Site

Central Nervous System Malignancies

Endocrine Cancers

Gastrointestinal Cancers

Genitourinary Cancers

Gynaecologic Malignancies

Haematologic Malignancies

Head and Neck Cancers

Imaging, Diagnosis and Staging

Lung and other Thoracic Tumours

Melanoma and other Skin Tumours

Palliative and Supportive Care

  • Complications of Treatment: includes infections, Alopecia, bleeding and thrombosis, cardiovascular toxicity, catheter management, electrolyte disorders, endocrine and metabolic complications, fatigue, gastrointestinal complications, hepatotoxicity, hypersensitivity, infertility/sterility/sexuality, lymphedoema, myelosuppression, nephrotoxicity, neurotoxicity, oral complications, pulmonary toxicity, second malignancy, and skin toxicity.
  • Supportive Care: includes nausea and vomiting, infections and neutropenia, anaemia, thrombocytopenia, marrow and peripheral-blood progenitor cells, organ protection, mucositis, malignant effusions, extravasation, oncologic emergencies, paraneoplastic syndromes, and nutritional support.
  • Psychosocial Aspects of Cancer: includes the evaluation and management of psychological and existential symptoms of cancer.
  • Palliative Care: includes end-of-life care, interdisciplinary care, pain management, symptom evaluation and management (dyspnoea, nausea and vomiting, constipation, diarrhoea, cancer-related fatigue, delirium, anorexia/cachexia and starvation), management of complications of cancer, communication, cultural competence, self care, and rehabilitation.

Patient Education

Pathology/Molecular Biology

Personalised Medicine: only includes treatments with proven biomarkers (those under investigation are found in "Translational Research")

Sarcoma

Translational Research

  • Biomarkers: only includes biomarkers which have been proven (others are found in "Translational Research")
  • Diagnostics

Surgery and/or Radiotherapy of Cancer

Last update: 24 January 2014